Investor Packs Material
- Director and Management Profiles ( pdf file, 109kb)
- 180219 Shareholder Update February 2018.pdf ( pdf file, 1MB)
- 180125 Quarterly Cashflow Report.pdf ( pdf file, 690kb)
- 180130 Bell Potter.pdf ( pdf file, 176kb)
- 171121 NDA submission for VivaGe.pdf ( pdf file, 166kb)
- 171025 VivaGel BV receives marketinga approval.pdf ( pdf file, 83kb)
- 170928_Astra_Zeneca_first_Starph.pdf ( pdf file, 138kb)
- 170922_DEP_docetaxel_positive_ph.pdf ( pdf file, 363kb)
- 170807 Successful VivaGel Phase.pdf ( pdf file, 424kb)
- 170614 Sale of Agrochemicals Bus.pdf ( pdf file, 986kb)
- 170606 DEP irinotecan update.pdf ( pdf file, 349kb)
- 170420 Starpharma AstraZeneca Milestone.pdf ( pdf file, 92kb)
- 170412 Ansell launches VivaGel in Canada.pdf ( pdf file, 65kb)
- 170112 VivaGel BV QIDP and Fast track.pdf ( pdf file, 89kb)
- 161028 Additional US Patent.pdf ( pdf file, 175kb)
- 160721 Starpharma signs license.pdf ( pdf file, 118kb)
- 171122 Bell Potter.pdf ( pdf file, 176kb)
- 170831 Bell Potter.pdf ( pdf file, 212kb)
- 170808 Bell Potter.pdf ( pdf file, 1MB
- 170615 Bell Potter.pdf ( pdf file, 641kb)
- 170614 Canaccord.pdf ( pdf file, 770kb)
- 170609 Bell Potter.pdf ( pdf file, 684kb)
- 170421_Bell_Potter.pdf ( pdf file, 131kb)
- 170112 Bell Potter.pdf ( pdf file, 105kb)
- 160913 Bell Potter.pdf ( pdf file, 110kb)
- 160829 Cannacord.pdf ( pdf file, 771kb)